Ascendis Pharma A/S News

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 17 06:08 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12 16:06 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 11 16:05 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 17:20 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 17:10 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 17:05 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 17:00 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 17:00 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 16:59 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 10 16:50 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 3 16:41 ET

Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 16:11 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(16.1%),Peter Kolchinsky(16.1%), etc.

Nov 14 17:51 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14 16:59 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14 16:23 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%)

Nov 14 15:02 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(2.9%)

Nov 14 13:34 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(8.2%),Behzad Aghazadeh(8.2%)

Nov 14 09:36 ET

Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 13 16:10 ET

Ascendis Pharma A/S | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Artisan Partners Limited Partnership(7.3%),Artisan Investments GP LLC(7.3%), etc.

Nov 12 09:55 ET